Dermatology Real-World Evidence Strategy Lead

Ucb

Slough

Hybrid

GBP 75,000 - 110,000

Full time

10 days ago

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

UCB, based in Slough, UK, seeks a Real-World Evidence Strategy Lead in Dermatology. This hybrid role requires 40% onsite presence, joining a global team to shape evidence across development, regulatory and market access.

You will lead studies, collaborate with safety, payer evidence and regional teams, and mentor colleagues while advancing evidence strategies throughout the product lifecycle.

Qualifications

  • Advanced degree in life sciences, medicine, epidemiology, statistics or related discipline.
  • At least eight years of pharmaceutical industry experience, preferably having worked in Dermatology and Immunology space.
  • Strong expertise in epidemiology, outcomes research and real-world evidence methodologies.
  • Experience developing evidence strategies across clinical development, regulatory and market access.
  • Strong cross-functional leadership, influencing, communication and stakeholder management skills and having lead teams.
  • Been a strong contributor or has lead Integrated Evidence roles.
  • Excellent written and spoken English, with proven scientific communication capabilities.

Responsibilities

  • Develop strategic real-world evidence plans supporting clinical, regulatory, access and patient needs.
  • Anticipate evidence gaps and identify innovative solutions across the product lifecycle.
  • Lead real-world evidence studies, ensuring quality, governance, timelines and budget delivery.
  • Partner across functions to align evidence strategies and stakeholder requirements.
  • Build productive relationships with external experts, influencers and research partners.
  • Lead and develop experts while supporting broader functional leadership and mentorship.

Skills

Epidemiology
Outcomes research
Real-world evidence
Leadership
Stakeholder mgmt
Integrated Evidence
English proficiency

Education

Advanced life sciences degree

Job description

UCB, based in Slough, UK, seeks a Real-World Evidence Strategy Lead in Dermatology. This hybrid role requires 40% onsite presence, joining a global team to shape evidence across development, regulatory and market access.

You will lead studies, collaborate with safety, payer evidence and regional teams, and mentor colleagues while advancing evidence strategies throughout the product lifecycle.

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Dermatology Real-World Evidence Strategy Lead — Hybrid
Dermatology Real-World Evidence Strategy Lead — Hybrid

UCB • Slough

Hybrid
GBP 110,000 - 150,000
Real-World Evidence Strategy Lead, Dermatology (UK)
Real-World Evidence Strategy Lead, Dermatology (UK)

UCB • Slough

Hybrid
GBP 110,000 - 150,000
Real-World Evidence Strategy Lead, Dermatology
Real-World Evidence Strategy Lead, Dermatology

Ucb • Slough

Hybrid
GBP 75,000 - 110,000
Respiratory Real-World Evidence Strategy Lead
Respiratory Real-World Evidence Strategy Lead

Ucb • Slough

Hybrid
GBP 110,000 - 160,000
Real-World Evidence Strategy Lead, Respiratory
Real-World Evidence Strategy Lead, Respiratory

Ucb • Slough

Hybrid
GBP 110,000 - 160,000
RWE Strategy Lead, Developed Brands (UK)
RWE Strategy Lead, Developed Brands (UK)

UCB • Slough

Hybrid
GBP 90,000 - 130,000
RWE Strategy Lead, Developed Brands (UK)
RWE Strategy Lead, Developed Brands (UK)

UCB S.A. • Princes Risborough

Hybrid
GBP 100,000 - 150,000
RWE Strategy Lead: Patient Impact & Access
RWE Strategy Lead: Patient Impact & Access

UCB • Slough

Hybrid
GBP 90,000 - 130,000
Global HEOR Strategy Lead, Payer & Value Insights
Global HEOR Strategy Lead, Payer & Value Insights

UCB S.A. • Slough

Hybrid
GBP 90,000 - 130,000
Hybrid work model
Global exposure
Global RWE Strategy Lead – Immunology (Hybrid)
Global RWE Strategy Lead – Immunology (Hybrid)

UCB S.A. • Princes Risborough

Hybrid
GBP 100,000 - 150,000